Publications by authors named "Beth DuPree"

Claim this Profile
R
Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
Pat Whitworth, Frank Vicini, Stephanie A Valente, Kirstyn Brownson, Beth DuPree

J Cancer Surviv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Chirag Shah, Pat Whitworth, Stephanie Valente, Graham S Schwarz, Megan Kruse, Beth Dupree

Breast Cancer Res Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul, Beth B Dupree

Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky, Beth B Dupree

JCO Precis Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee, Beth Dupree

Ann Surg Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
Pat W Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee, Beth B Dupree

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel, adaptable, radiographically opaque, multi-plane continuous filament marker for optimizing tissue identification, radiation planning, and radiographic follow-up.
Sunny Mitchell, Henry Lee, Beth Baughman DuPree, David C Beyer, Michael Ulissey

Gland Surg· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Survivorship: Why, What and When?
Jennifer Gass, Beth Dupree, Sandhya Pruthi, Diane Radford, Irene Wapnir

Ann Surg Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis